A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis-Reference-Cited by-同舟云学术

A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis

Published:2017-07-20 Issue:1 Volume:19 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Jamshidi Ahmadreza^ORCID,Gharibdoost Farhad,Vojdanian Mahdi,Soroosh Soosan G.,Soroush Mohsen,Ahmadzadeh Arman,Nazarinia Mohammad Ali,Mousavi Mohammad,Karimzadeh Hadi,Shakibi Mohammad Reza,Rezaieyazdi Zahra,Sahebari Maryam,Hajiabbasi Asghar,Ebrahimi Ali Asghar,Mahjourian Najmeh,Rashti Amin Mohammadinejad

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-017-1371-4.pdf

Reference35 articles.

1. Bértolo MB, Brenol CV, Schainberg CG, Neubarth F, Lima FAC, Laurindo IM, et al. Atualização do consenso brasileiro no diagnóstico e tratamento da artrite reumatóide. Rev Bras Reumatol. 2007;47:151–9.

2. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429–42.

3. Tugwell P. Pharmacoeconomics of drug therapy for rheumatoid arthritis. Rheumatology (Oxford). 2000;39:43–7.

4. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358(9285):903.

5. Kwoh CK, Anderson LG, Greene JM, Johnson DA, O'Dell JR, Robbins ML, Roberts WN, Simms RW, Yood RA. Guidelines for the management of rheumatoid arthritis: 2002 update-American College ofRheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Arthritis Rheum. 2002;46(2):328-46.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis;Modern Rheumatology;2024-05-30

2. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

3. Systemic review of safety and efficacy of approved bio similar for management of rheumatoid arthritis;Indian Journal of Orthopaedics Surgery;2024-03-15

4. Demyelinating plaque-associated uveitis;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-10-19

5. Leukocytoclastic vasculitis induced by adalimumab biosimilar in an elderly female with rheumatoid arthritis: A case-based review;The Egyptian Rheumatologist;2023-06